Roles of porin and β-lactamase in β-lactam resistance of pseudomonas aeruginosa

Clinical Infectious Diseases

Volumn 10, Issue 4, 1988, Pages 770-775

  Hancock, Robert E W ^a   Woodruff, Wendy A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASES; OUTER MEMBRANE PROTEIN; PORIN;

ANTIBIOTIC RESISTANCE; CELL MEMBRANE PERMEABILITY; DRUG EFFECT; ENZYMOLOGY; ION CHANNEL; METABOLISM; PSEUDOMONAS AERUGINOSA; REVIEW;

ANTIBIOTICS, LACTAM; BACTERIAL OUTER MEMBRANE PROTEINS; BETA-LACTAMASES; CELL MEMBRANE PERMEABILITY; DRUG RESISTANCE, MICROBIAL; ION CHANNELS; PORINS; PSEUDOMONAS AERUGINOSA; SUPPORT, NON-U.S. GOV'T;

EID: 0024042262     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/10.4.770     Document Type: Article

References (39)

1. Sykes RB, Matthew M. The P-lactamases of gram-negative bacteria and their role in resistance to P-lactam antibiotics. J Antimicrob Chemother 1976;2:115-57
2. Nordstrom K, Sykes RB. Induction kinetics of P-lactamase biosynthesis in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1974;6:734-40
3. Sanders CC, Sanders WE. Type I P-lactamases of gramnegative bacteria: Interactions with p-lactam antibiotics. J Infect Dis 1986;154:792-800
4. Angus BL, Carey AM, Caron D, Kropinski AMB, Hancock REW. Outer membrane permeability in Pseudomonas aeruginosa: Comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrob Agents Chemother 1982;21:299-309
5. Dalhoff A, Cullmann W. Specificity of p-lactamase induction in Pseudomonas aeruginosa. J Antimicrob Chemother 1984;14:349-57
6. Rosselet A, Zimmermann W. Mutants of Pseudomonas aeruginosa with impaired P-lactamase inducibility and increased sensitivity to P-lactam antibiotics. J Gen Microbiol 1973; 76:455-7
7. Ohmori H, Azuma A, Suzuki Y, Hashimoto Y. Isolation and properties of P-lactamase-less mutants from clinically important gram-negative bacteria. J Antibiot 1977;30:267-9
8. Curtis NAC, Eisenstadt RL, Rudd C, White AJ. Inducible type I P-lactamases of gram-negative bacteria and resistance to P-lactam antibiotics. J Antimicrob Chemother 1986;17:51-61
9. Bayer AS, Peters J, Parr TR, Chan L, Hancock REW. Role of P-lactamase in in vivo development of ceftazidime resistance in an experimental Pseudomonas aeruginosa endocarditis model. Antimicrob Agents Chemother 1987; 31:253-8
10. Rolinson GN. P-Lactam antibiotics. J Antimicrob Chemother 1986;17:5-36
11. Brown MRW. The role of the cell envelope in resistance. In: Brown MRW, ed. Resistance of Pseudomonas aeruginosa. New York: John Wiley, 1975:71-107
12. Bryan LE. Resistance to antimicrobial agents: The general nature of the problem and the basis of resistance. In: Dog-gett RG, ed. Pseudomonas aeruginosa: Clinical manifestations of infection and current therapy. New York: Academic Press, 1979:219-70
13. Nicas TI, Hancock REW. Pseudomonas aeruginosa outer membrane permeability: Isolation of a porin protein F-defi-cient mutant. J Bacteriol 1983;153:281-5
14. Yoshimura F, Nikaido H. Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes. J Bacteriol 1982;152:636-42
15. Woodruff WA, Parr TR, Hancock REW, Hanne LF, Nicas TI, Iglewski BH. Expression in Escherichia coli and function of Pseudomonas aeruginosa outer membrane porin protein F. J Bacteriol 1986;167:473-9
16. Benz R, Hancock REW. Properties of the large ion-permeable pores formed from protein F of Pseudomonas aeruginosa in lipid bilayer membranes. Biochim Biophys Acta 1981; 646:298-308
17. Yoshimura F, Zalman LS, Nikaido H. Purification and properties of Pseudomonas aeruginosa porin. J Biol Chem 1983;258:2308-14
18. Miller RV, Becker JM. Peptide utilization in Pseudomonas aeruginosa: Evidence for membrane-associated peptidase. J Bacteriol 1978;133:165-71
19. Becker JM, Naider F. Stereospecificity of tripeptide utilization in a methionine auxotroph of Escherichia coli K-12. J Bacteriol 1974;120:191-6
20. Moore RA, Woodruff WA, Hancock REW. Antibiotic uptake pathways across the outer membrane of Pseudomonas aeruginosa. Antibiot Chemother 1986;39:172-81
21. Ohman DE, West MA, Flynn JL, Goldberg JB. Method of gene replacement in Pseudomonas aeruginosa used in construction of recA mutants: Reca-independent instability of alginate production. J Bacteriol 1985;162:1068-74
22. Woodruff WA, Hancock REW. Construction and characterization of Pseudomonas aeruginosa porin protein F deficient mutants after in vivo and in vitro insertion mutagenesis of the cloned gene in Escherichia coli. J Bacteriol 1988 (in press).
23. Goldberg JB, Ohman DE. Construction and characterization of Pseudomonas aeruginosa o/gB mutants: Role of algB in high-level production of alginate. J Bacteriol 1987; 169:1593-602
24. Hancock REW, Carey AM. Protein Dl a glucose-inducible, pore-forming protein from the outer membrane of Pseudomonas aeruginosa. FEMS Microbiology Letters 1980; 8:105-9
25. Quinn JP, Dudek EJ, DiVincenzo CA, Lucks DA, Lerner SA. Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. J Infect Dis 1986;154:289-94
26. 26 Buscher K-H, Cullmann W, Dick W, Opferkuch W. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein. Antimicrob Agents Chemother 1987;31:703-8
27. Angus BL, Fyfe JAM, Hancock REW. Mapping and characterization of two mutations to antibiotic supersuscepti-bility in Pseudomonas aeruginosa. J Gen Microbiol 1987;133:2905-14
28. Angus BL, Fyfe JAM, Hancock REW. The hydrophobic uptake pathway across the outer membrane of the antibiotic supersusceptible Pseudomonas aeruginosa mutant Z61. FEMS Microbiology Letters 1987;48:153-7
29. Godfrey AJ, Bryan LE. Penetration of P-lactams through Pseudomonas aeruginosa porin channels. Antimicrob Agents Chemother 1987;31:1216-21
30. Hancock REW. Intrinsic antibiotic resistance of Pseudomonas aeruginosa. J Antimicrob Chemother 1986;18:653-6
31. Kelly NM, Battershill JL, Kuo S, Arbuthnott JP, Hancock REW. Colonial dissociation and susceptibility to opsonized phagocytosis of Pseudomonas aeruginosa grown in a chamber implant model in mice. Infect Immun 1987;55:2841-3
32. Hancock REW. Model membrane studies of porin function. In: Inouye M, ed. Bacterial outer membranes as model systems. New York: John Wiley, 1986:187-225
33. Yaginuma S, Sawai T, Ono H, Yamagishi S, Mitsuhashi S. Biochemical properties of a cephalosporin P-lactamase from Pseudomonas aeruginosa. Jpn J Microbiol 1973;17:141-9
34. Vu H, Nikaido H. Role of a P-lactam hydrolysis in the mechanism of resistance of a P-lactamase-constitutive Entero-bacter cloacae strain to expanded-spectrum P-lactams. Antimicrob Agents Chemother 1985;27:393-8
35. Pedersen SS, Pressler T, Jensen T, Rosdahl VT, Bentzon MW, Hoiby N, Koch C. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis. J Antimicrob Chemother 1987; 19:101-7
36. Jaffe A, Chabbert YA, Semonin O. Role of porin proteins OmpF and OmpC in the permeation of p-lactams. Antimicrob Agents Chemother 1982;22:942-8
37. Komatsu Y, Murakami K, Nishikawa T. Penetration of moxalactam into its target proteins in Escherichia coli K-12: Comparison of a highly moxalactam-resistant mutant with its parent strain. Antimicrob Agents Chemother 1981;20:613-9
38. Harder KJ, Nikaido H, Matsuhashi M. Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin. Antimicrob Agents Chemother 1981;20:549-52
39. Curtis NAC, Eisenstadt RL, Turner KA, White AJ. Porinmediated cephalosporin resistance in Escherichia coli K-12 [letter]. J Antimicrob Chemother 1985;15:642-4